13 completed, 3 not yet recruiting, 3 unknown, 1 recruiting. 21 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 21 | Completed 13, Not yet recruiting 3, Unknown 3, Recruiting 1, Terminated 1 |
Follow Mesalamine: new trials by email Literature Review of Mesalamine trials Research Report on Mesalamine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comaprison of Efficacy and Safety Between Etrasimod vs Mesalazine in Chinese Adults With Active UC Etrasimod, mesalazine - Etrasimod, Mesalazine | Phase 4 | Not yet recruiting | Sir Run Run Shaw Hospital | 320 | 2026-07-31 | 2026-08-24 |
| Combined Application of EEN in the Induction of Remission in PUC exclusive enteral nutrition, regular food - Exclusive Enteral Nutrition, Ulcerative Colitis | Phase 4 | Not yet recruiting | Children's Hospital of Fudan University | 40 | 2025-03-01 | 2024-07-03 |
| TOFACITINIB vs TOFACITINIB WITH MESALAMINE IN ULCERATIVE COLITIS Tofacitinib, Tofacitinib plus mesalamine - Ulcerative Colitis | Phase 4 | Not yet recruiting | Post Graduate Institute of Medical Education and Research, Chandigarh | 75 | 2024-10-01 | 2024-10-03 |
| Role of Roflumilast in Ulcerative Colitis Roflumilast 500 MCG Oral Tablet [DALIRESP], amino salicylic acid - Ulcerative Colitis | Phase 4 | Completed | Tanta University | 52 | 2023-02-01 | 2025-01-28 |
| Efficacy of Mesalazine Combined With Biologics in the Treatment of Moderate to Severe Ulcerative Colitis Infliximab, Vedolizumab, Mesalazine - Ulcerative Colitis, Efficacy, Self | Phase 4 | Completed | Sixth Affiliated Hospital, Sun Yat-sen University | 438 | 2022-01-15 | 2026-04-29 |
| Top Down Versus Step up in Pediatric Ulcerative Colitis Infliximab, Corticosteroids - Ulcerative Colitis, Infliximab | Phase 4 | Recruiting | Children's Hospital of Fudan University | 40 | 2021-11-01 | 2024-02-28 |
| Adherence of a 1.600 mg Single Tablet 5-ASA Treatment of Ulcerative Colitis Mesalazine - Ulcerative Colitis | Phase 4 | Unknown | Flemming Bendtsen | 200 | 2019-11-28 | 2023-09-26 |
| Mesalazine With Hydrocortisone Sodium Succinate Enema for 4-Week Treatment in Patients With Ulcerative Colitis Mesalazine, hydrocortisone sodium succinate, Mesalazine with hydrocortisone sodium succinate - Ulcerative Colitis, Unspecified | Phase 4 | Unknown | Xijing Hospital of Digestive Diseases | 528 | 2017-05-01 | 2017-04-12 |
| Corticosteroids+5-aminosalicylic Acid Compared to Corticosteroids in the Treatment of Moderate-severe Ulcerative Colitis oral 5-ASA+/-topical 5-ASA+IV corticosteroids / PO Methylprednisolone, corticosteroids only - Ulcerative Colitis | Phase 4 | Completed | Sheba Medical Center | 149 | 2013-09-01 | 2022-05-09 |
| Cimzia Versus Mesalamine for Crohn's Recurrence Cimzia, Mesalamine - Crohn's Disease | Phase 4 | Terminated | Milton S. Hershey Medical Center | 10 | 2013-02-01 | 2018-01-12 |
| Predicting Response to Standardized Pediatric Colitis Therapy Mesalazine, IV Corticosteroid, Oral Corticosteroids - Ulcerative Colitis | Phase 4 | Completed | Connecticut Children's Medical Center | 431 | 2012-07-10 | 2019-09-20 |
| Mesalazine for the Treatment of Diarrhoea-predominant Irritable Bowel Syndrome (IBS-D) Mesalazine, Placebo - Irritable Bowel Syndrome With Diarrhoea | Phase 4 | Completed | University of Nottingham | 108 | 2011-03-01 | 2014-01-17 |
| Once Versus Twice Daily Mesalamine to Induce Remission in Pediatric Ulcerative Colitis Mesalamine - Mild to Moderate Ulcerative Colitis | Phase 4 | Completed | Wolfson Medical Center | 86 | 2010-09-01 | 2015-12-08 |
| Ability to Maintain or Achieve Clinical and Endoscopic Remission With MMX Mesalamine Once Daily in Adults With Ulcerative Colitis MMX mesalamine/ mesalazine - Ulcerative Colitis | Phase 4 | Completed | Shire | 759 | 2010-06-29 | 2021-06-09 |
| Mesalamine to Reduce T Cell Activation in HIV Infection Mesalamine (5-aminosalicylic acid, Apriso), Placebo - HIV Infections, Sexually Transmitted Diseases | Phase 4 | Completed | University of California, San Francisco | 33 | 2010-06-01 | 2014-08-13 |
| Mesalazine and/or Lactobacillus Casei in the Diverticular Disease of the Colon Mesalazine plus Lactobacillus casei, Mesalazine placebo plus Lactobacillus casei placebo, Mesalazine 800 mg - Diverticular Disease of the Colon | Phase 4 | Completed | Hospital Cristo Re | 250 | 2009-01-01 | 2012-02-17 |
| Clinical Management of Childhood Intestinal Lymphoid Nodular Hyperplasia Mesalamine, DIET - Intestinal LNH | Phase 4 | Unknown | Azienda Policlinico Umberto I | 270 | 2008-11-01 | 2013-02-12 |
| Dose Escalation and Remission (DEAR) mesalamine - Ulcerative Colitis | Phase 4 | Completed | James Lewis | 119 | 2008-09-01 | 2015-05-05 |
| Strategies in Maintenance for Patients Receiving Long-term Therapy (S.I.M.P.L.E.) With MMX (Multi-Matrix System) Mesalamine for Ulcerative Colitis (UC) MMX Mesalamine - Ulcerative Colitis | Phase 4 | Completed | Shire | 290 | 2007-05-01 | 2021-06-14 |
| The Influence of 5-Aminosalicylates on Thiopurine Metabolite Levels 5-aminosalicylate (Pentasa, Ferring) - Crohn's Disease, Ulcerative Colitis | Phase 4 | Completed | Amsterdam UMC, location VUmc | 24 | 2005-07-01 | 2006-09-11 |
Showing 20 of 21. Sign in to see all of them.
Colitis, Ulcerative (16) · Crohn Disease (2) · Inflammatory Bowel Diseases (2) · Acquired Immunodeficiency Syndrome (1) · Charcot-Marie-Tooth disease, Type 1C (1) · Diarrhea (1) · Food Hypersensitivity (1) · HIV Infections (1) · Immune System Diseases (1) · Lentivirus Infections (1) · Patient Compliance (1) · Recurrence (1) · Sexually Transmitted Diseases (1)
Children's Hospital of Fudan University (2) · Shire (2) · Amsterdam UMC, location VUmc (1) · Azienda Policlinico Umberto I (1) · Connecticut Children's Medical Center (1) · Flemming Bendtsen (1) · Hospital Cristo Re (1) · James Lewis (1) · Milton S. Hershey Medical Center (1) · Post Graduate Institute of Medical Education and Research, Chandigarh (1) · Sheba Medical Center (1) · Sir Run Run Shaw Hospital (1) · Sixth Affiliated Hospital, Sun Yat-sen University (1) · Tanta University (1) · University of California, San Francisco (1)
United States (7) · China (4) · Italy (3) · Canada (2) · France (2) · Israel (2) · United Kingdom (2) · Belgium (1) · Colombia (1) · Czechia (1) · Denmark (1) · Egypt (1) · Germany (1) · Greece (1) · Hungary (1)
Ying Huang (2) · Arie Levine, MD (1) · Batia Weiss, MD (1) · Dan Turner, MD, PhD (1) · David B Stewart, MD (1) · Flemming Bendtsen, MDSci (1) · Giovanni Brandimarte, M.D. (1) · James D Lewis, MD, MSCE (1) · Jeffrey Hyams, MD (1) · Lee Denson, MD (1) · Ofir Har-Noy, MD (1) · Robin C Spiller, MD (1) · Ron Shaoul, MD (1)
PMID 21837775, PMID 23957734, PMID 24793028, PMID 25193617, PMID 25545673, PMID 25765462, PMID 28939374, PMID 29361097, PMID 30294708, PMID 30935734, PMID 31373712, PMID 32801008, PMID 35272029, PMID 36871574, PMID 40955556, PMID 41043449, PMID 41105168
2009 (1), K24DK078228 (1), U34DK090804 (1)